-transparent.png){kind=logo}
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. 1990
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
Department of Molecular Biology Research, Upjohn Company, Kalamazoo, Michigan 49007.
A human myelomonocytic cell line, U937, produced an interleukin-1 (IL-1) receptor antagonist protein (IRAP) which was purified and partially sequenced. A complementary DNA coding for IRAP was cloned and sequenced. The mature translation product of the cDNA has been expressed in Escherichia coli and was an active competitive inhibitor of the binding of IL-1 to the T-cell/fibroblast form of the IL-1 receptor. Recombinant IRAP specifically inhibited IL-1 bioactivity on T cells and endothelial cells in vitro and was a potent inhibitor of IL-1 induced corticosterone production in vivo.
Related Publications
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
November 1991,
European journal of immunology,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
March 1994,
The Journal of biological chemistry,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
May 1997,
Veterinary immunology and immunopathology,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
August 1995,
The Journal of experimental medicine,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
August 1990,
The Journal of biological chemistry,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
October 2023,
Biotechnology and applied biochemistry,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
March 1995,
Archives of pathology & laboratory medicine,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
November 2000,
Annals of the rheumatic diseases,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
March 1997,
Journal of dermatological science,
D B Carter, and
M R Deibel, and
C J Dunn, and
C S Tomich, and
A L Laborde, and
J L Slightom, and
A E Berger, and
M J Bienkowski, and
F F Sun, and
R N McEwan
May 2008,
Protein expression and purification,
